# Oramed Pharmaceuticals Inc.: Form 8-K, filed Apr 4, 2022

- Company: [Oramed Pharmaceuticals Inc.](/companies/ormp.md) (CIK 1176309)
- Form: 8-K
- Filed: 2022-04-04
- Accepted by EDGAR: Apr 4, 2022, 08:25 ET
- Period: 2022-03-30
- Accession: 0001213900-22-017667
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1176309/000121390022017667/ea157933-8k_oramedphar.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1176309/000121390022017667/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1176309/000121390022017667/ea157933-8k_oramedphar.htm

Filed Apr 4, 2022.
Source: SEC EDGAR, the filing index for accession 0001213900-22-017667. Last ingested by Listed: Nov 15, 2026, 04:14 ET. No prices; not investment advice.
